Products
AI Benchmark
Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
$29/mo
Higher than 70% of peersNiche median $19/mo
Creators
Lead Vora
No social account linked
Launched
5mo ago
2026-06-21 · Est.

Traffic

Last 12 months
Monthly visitsData through Oct 2026
Events1 marketing move

Marketing moves

Launches, search & content, referrals, promotions
  • Launched on Product HuntLaunch

    Stop Undercharging. Start Growing.

    Jun 21 · 5mo agoLaunch page

Traffic sources

Oct 2026

Traffic breakdown

Channels

No data yet

Countries

No data yet

Search

Domain authority —Domain registered 2018-05-08

No search keyword data for this website yet.

Traffic data: Vaneform

Pricing

Starter
Free
3 Saved Calculations
Pro
$29/mo
Unlimited Saved Calculations
Business
$79/mo

Trial: try Pro with a 14-day free trial. · Free tier included · 2 paid tiers ($29–$79) · Observed 2026-11-08 · Source page

Entry price $29/mo, Higher than 70% of peers; “Agency & Freelancer Operations” median is $19/mo.View pricing benchmark

Pages & changes

Tracked since 2026-06-21

Key pages

Weekly snapshots
Home
prezzo.netlify.app/ Snapshot 2026-11-08

Changes

No pricing, plan, or positioning changes detected since tracking started.

Questions & evidence

How much does Prezzo cost?
Starter: Free; Pro: $29/mo; Business: $79/mo. Observed 2026-11-08. Check the source for current billing terms, usage limits and taxes.Source
How much website traffic does Prezzo get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is Prezzo and what platforms does it support?
Prezzo is catalogued under Agency & Freelancer Operations: Stop Undercharging Your Clients. Supported platforms: API.

Related products in this category

Business Operations / Agency & Freelancer Operations

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.